These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 7571477

  • 1. [Morphologic findings in liver tissue in chronic active hepatitis B after seroconversion from HBeAg to anti-HBe].
    Chlumská A, Stránský J, Taimr P, Baumruk L, Nevaril M.
    Vnitr Lek; 1995 Jul; 41(7):445-8. PubMed ID: 7571477
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical and pathophysiological aspects of chronic active hepatitis.
    Iwamura K.
    Tokai J Exp Clin Med; 1986 Jul; 11 Suppl():147-57. PubMed ID: 3452239
    [Abstract] [Full Text] [Related]

  • 6. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
    Takahashi A, Sekiya C, Yazaki Y, Tominaga Y, Oohara K, Ono M, Sato H, Hasebe C, Namiki M.
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
    [Abstract] [Full Text] [Related]

  • 7. A 13-year longitudinal study of the impact of double mutations in the core promoter region of hepatitis B virus on HBeAg seroconversion and disease progression in patients with genotype C chronic active hepatitis.
    Jang JW, Lee YC, Kim MS, Lee SY, Bae SH, Choi JY, Yoon SK.
    J Viral Hepat; 2007 Mar; 14(3):169-75. PubMed ID: 17305882
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.
    Hsu YS, Chien RN, Yeh CT, Sheen IS, Chiou HY, Chu CM, Liaw YF.
    Hepatology; 2002 Jun; 35(6):1522-7. PubMed ID: 12029639
    [Abstract] [Full Text] [Related]

  • 10. Effects of alcohol on the liver in HBsAg carriers.
    Itoh S, Shimoji K.
    Am J Gastroenterol; 1986 Sep; 81(9):779-82. PubMed ID: 3752040
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection.
    Bozkaya H, Ayola B, Lok AS.
    Hepatology; 1996 Jul; 24(1):32-7. PubMed ID: 8707278
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B.
    Fattovich G, Rugge M, Brollo L, Pontisso P, Noventa F, Guido M, Alberti A, Realdi G.
    Hepatology; 1986 Jul; 6(2):167-72. PubMed ID: 3957228
    [Abstract] [Full Text] [Related]

  • 17. Chronic hepatitis B. Impact of hepatitis D virus superinfection and the hepatitis B e-system on histological outcome, and correlation of the hepatitis B e-system to HBV-DNA in serum.
    Lindh G.
    Scand J Infect Dis Suppl; 1986 Jul; 50():1-45. PubMed ID: 3468608
    [Abstract] [Full Text] [Related]

  • 18. Low frequency of precore hepatitis B virus mutants in anti-hepatitis B e-positive reactivation after loss of hepatitis B e antigen in patients with chronic hepatitis B.
    Loriot MA, Marcellin P, Talbodec N, Guigonis V, Gigou M, Boyer N, Bezeaud A, Erlinger S, Benhamou JP.
    Hepatology; 1995 Mar; 21(3):627-31. PubMed ID: 7875659
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.